The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call
The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call
CERRITOS, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC ("TOI") (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its first quarter 2024 financial results after the market close on Tuesday, May 14, 2024, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
加利福尼亞州塞裏託斯，2024年4月23日（GLOBE NEWSWIRE）——美國最大的基於價值的腫瘤組織之一腫瘤學研究所有限責任公司（“TOI”）（納斯達克股票代碼：TOI）今天宣佈，該公司將在2024年5月14日星期二收盤後發佈其2024年第一季度財務業績，隨後將在當天下午5點（東部時間）舉行電話會議。
The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13746255. The replay will be available until Tuesday, May 21, 2024.
撥打 1-877-407-0789 可以通過電話直播電話會議，國際來電者撥打 1-201-689-8562。電話會議結束兩小時後將提供重播，可撥打1-844-512-2921觀看，國際來電者可撥打1-412-317-6671觀看。直播和重播的密碼是13746255。重播將持續到2024年5月21日星期二。
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company's website at
感興趣的投資者和其他各方也可以登錄公司網站的 “投資者關係” 部分，收聽電話會議的同步網絡直播
About The Oncology Institute
關於腫瘤研究所
Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit .
腫瘤學研究所及其附屬公司（納斯達克股票代碼：TOI）成立於2007年，通過在社區環境中提供高度專業化、基於價值的癌症護理來推動腫瘤學發展。TOI爲超過180萬名患者提供尖端的循證癌症護理，包括臨床試驗、輸血和傳統上與最先進的醫療服務組織相關的其他護理提供模式。TOI 擁有 110 多名臨床醫生和 70 多個診所，而且還在不斷增長，正在使腫瘤學向更好的方向發展。欲了解更多信息，請訪問。
Investors
投資者
Solebury Strategic Communications
investors@theoncologyinstitute.com
索爾伯裏戰略傳播
investors@theoncologyinstitute.com
譯文內容由第三人軟體翻譯。